Infinant Health
We're changing the trajectory of human health, one baby at a time. Intent on a world without debilitating disease.
We're changing the trajectory of human health, one baby at a time. Intent on a world without debilitating disease.
Infinant Health is a biotechnology and healthcare startup founded in 2012, dedicated to revolutionizing human health, particularly in infants. The company's mission is encapsulated in their slogan, "We're changing the trajectory of human health, one baby at a time. Intent on a world without debilitating disease."
Infinant Health has delved into extensive research on infant nutrition and the gut microbiome, leading to a groundbreaking discovery of B. infantis EVC001, a natural bacterial strain crucial for infant immune health. This specific strain was found to be essential in developing a healthy microbiome and supporting a robust immune system, particularly vital in pre-term infants to prevent diseases like necrotizing enterocolitis (NEC).
Investors include Cargill and the Bill & Melinda Gates Foundation, among others, positioning the company for significant growth and influence in the future of infant health. The innovative approach of Infinant Health, along with its reputable investors, demonstrates strong potential for societal impact and financial success.
There is no investment information
No recent news or press coverage available for Infinant Health.
We care about your data, and we'd love to use cookies make your experience better.
